المتخصصون في المجالات الطبية

Overview

CAR-T Cell Therapy: Current Uses and Future Possibilities

Chimeric antigen receptor (CAR)-T cell therapy is a promising new immunotherapy for certain cancers of the blood, providing long-lasting responses for some patients. It genetically modifies T cells to make them specific for cancer cell markers and activates the immune system to destroy cancer cells. Physicians with the CAR-T cell therapy program at Mayo Clinic in Jacksonville, Florida, will discuss current uses and potential future applications. Mayo Clinic’s program includes an in-house cell manufacturing facility for developing new cutting-edge trials.

Target Audience:
Webinar is open to physicians, physician assistants, nurses, nurse practitioners, residents, fellows, pharmacists, social workers, scientists, students, and allied health professionals. Also for medical directors or others from contracted organizations.

Learning Objectives:

• Understand how CAR-T cell therapy is provided.
• Learn about its current use in treating lymphoma and multiple myeloma.
• Learn about potential future indications, including for cancers for which there is no treatment.

Additional Resources:

• Car T-Cell therapy: A new approach in the fight against cancer
• ADVANCING BREAKTHROUGH CAR-T CELL THERAPY TO FIGHT BLOOD CANCER
• CAR T-Cell Therapy Innovations

Moderators:

• Sikander Ailawadhi, M.D., Hematology/Oncology, Mayo Clinic Comprehensive Cancer Center

Speakers:

• Mohamed A. Kharfan-Dabaja, M.D., M.B.A., Vice Chair of Hematology and Director of Blood Marrow and Transplantation and Cellular Therapies, Mayo Clinic in Florida
• Ricardo D. Parrondo, M.D., Hematology/Oncology, Mayo Clinic in Florida
• Hemant S. Murthy, M.D., Hematology/Oncology, Mayo Clinic in Florida